[1]
D. P. Destiani, “COST-EFFECTIVENESS ANALYSIS OF CEFTAZIDIME-LEVOFLOXACIN AND CEFOTAXIME-ERYTHROMYCIN AS EMPIRICAL ANTIBIOTIC COMBINATIONS IN RESPIRATORY INFECTION-INDUCED SEPSIS”, Asian J Pharm Clin Res, vol. 10, no. 14, pp. 119–121, May 2017.